Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer
Condition(s):Urothelial Carcinoma of the BladderLast Updated:November 26, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Urothelial Carcinoma of the BladderLast Updated:November 26, 2019Completed
Condition(s):Urinary Bladder NeoplasmsLast Updated:January 8, 2024Recruiting
Condition(s):Urothelial Carcinoma of the BladderLast Updated:December 11, 2023Active, not recruiting
Condition(s):Bladder CancerLast Updated:July 7, 2020Withdrawn
Condition(s):Urothelial CarcinomaLast Updated:February 23, 2022Unknown status
Condition(s):Bladder Cancer TNM Staging Primary Tumor (T) T2; Bladder Cancer TNM Staging Primary Tumor (T) T2A; Bladder Cancer TNM Staging Primary Tumor (T) T2B; Bladder Cancer TNM Staging Primary Tumor (T) T3; Bladder Cancer TNM Staging Primary Tumor (T) T3A; Bladder Cancer TNM Staging Primary Tumor (T) T3B; Bladder Cancer TNM Staging Regional Lymph Node (N) N0; Bladder Cancer TNM Staging Regional Lymph Node (N) N1; Bladder Cancer TNM Staging Distant Metastasis (M) M0Last Updated:July 14, 2020Terminated
Condition(s):Metastatic Ureter Carcinoma; Metastatic Urethral Carcinoma; Stage III Bladder Urothelial Carcinoma AJCC v6 and v7; Stage III Ureter Cancer AJCC v7; Stage III Urethral Cancer AJCC v7; Stage IV Bladder Urothelial Carcinoma AJCC v7; Stage IV Ureter Cancer AJCC v7; Stage IV Urethral Cancer AJCC v7; Ureter Urothelial Carcinoma; Urethral Urothelial CarcinomaLast Updated:December 16, 2019Completed
Condition(s):Urinary Bladder CancerLast Updated:March 10, 2020Completed
Condition(s):Bladder CancerLast Updated:July 24, 2008Unknown status
Condition(s):Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral CancerLast Updated:May 27, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.